Increased requirement for central venous catheter replacement in paediatric oncology patients with deep venous thrombosis: A multicentre study

Ketan Kulkarni; Jaqueline Halton; Maria Spavor; Sara J. Israels; Sharon Abish; Jian Yong; Yutaka Yasui; Lesley G. Mitchell

doi:10.1160/TH14-07-0626

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2015; 113(02): 434-435
DOI: 10.1160/TH14-07-0626

Letter to the Editor

Schattauer GmbH

Increased requirement for central venous catheter replacement in paediatric oncology patients with deep venous thrombosis: A multicentre study

Authors

Ketan Kulkarni

¹Stollery Children’s Hospital, Edmonton, Alberta, Canada
Jaqueline Halton

²Children’s Hospital of Eastern Ontario, Ottawa, Ontario, Canada
Maria Spavor

¹Stollery Children’s Hospital, Edmonton, Alberta, Canada
Sara J. Israels

³Winnipeg Children’s Hospital, Winnipeg, Manitoba, Canada
Sharon Abish

⁴Montreal Children’s Hospital, Montreal, Quebec, Canada
Jian Yong

⁵University of Alberta, Edmonton, Alberta, Canada
Yutaka Yasui

⁵University of Alberta, Edmonton, Alberta, Canada
Lesley G. Mitchell

¹Stollery Children’s Hospital, Edmonton, Alberta, Canada

⁵University of Alberta, Edmonton, Alberta, Canada

Abstract

Full Text

References

References
1 Farinasso L, Bertorello N, Garbarini L. et al. Risk factors of central venous lines-related thrombosis in children with acute lymphoblastic leukemia during induction therapy: a prospective study. Leukemia 2007; 21: 552-556.
2 Mitchell LG, Andrew M, Hanna K. et al. A prospective cohort study determining the prevalence of thrombotic events in children with acute lym-phoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study. Cancer 2003; 97: 508-516.
3 Howlader N, Noone AM, Krapcho M. et al. http://seer.cancer.gov/csr/1975_2008. 2011
4 Spagrud LJ, von Baeyer CL, Ali K. et al. Pain, distress, and adult-child interaction during venipunc-ture in pediatric oncology: an examination of three types of venous access. J Pain Symptom Manag 2008; 36: 173-184.
5 Olson JD, Arkin CF, Brandt JT. et al. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy. Arch Pathol Lab Med 1998; 122: 782-798.
6 Male C, Chait P, Andrew M. et al. Central venous line-related thrombosis in children: association with central venous line location and insertion technique. Blood 2003; 101: 4273-4278.
7 Chopra V, Anand S, Hickner A. et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet 2013; 382: 311-325..
8 Revel-Vilk S, Yacobovich J, Tamary H. et al. Risk factors for central venous catheter thrombotic complications in children and adolescents with cancer. Cancer 2010; 116: 4197-4205.